Search clinical trials for: Viral Proteins

Total 26145 results

Vachira Phuket Hospital

Recruiting

Correlation of Antibody Response to COVID-19 Vaccination in Pregnant Woman and Transplacental Passage Into Cord Blood.

Covid-19

Thailand
Johns Hopkins University
Stony Brook University; Rutgers University; Nepal Health Research Council; Bharatpur...

Recruiting

Evaluating Emetine for Viral Outbreaks (EVOLVE) (EVOLVE)

COVID-19

United States, Nepal
Patan Academy of Health Sciences
Gulmidarbar Rural Municipality; Dhurkot Rural Municipality; Resunga Municipality

Recruiting

Comparison of Rates of Antimicrobial Use in Febrile Patients With or Without the Use of C-reactive Protein Blood Test (CREATIB)

Acute Febrile Illness | Use of Antimicrobial Agents | C-reactive Protein Level

Nepal
Kafrelsheikh University

Not yet recruiting

Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety. (Isotretinoin)

Covid19 Vaccine
Sinocelltech Ltd.

Recruiting

The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19

Covid19

United States, Argentina, Brazil, Chile, Colombia, Mexico, Peru
INanoBio Inc.
TMC HealthCare

Recruiting

Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients (SARS-CoV-2)

COVID-19 | SARS-CoV-2 Infection

United States
Duke University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) (POPS or POP02)

Heart Failure | Pain | Pneumonia | Hypertension | Edema | Hemophilia | Insomnia | Pulmonary Arterial Hypertension | Coagulation Disorder | Asthma in Children | Down Syndrome | Attention Deficit Hyperactivity Disorder | Bronchopulmonary Dysplasia | Hypokalemia | Hyperphosphatemia | Primary Hyperaldosteronism | Adrenal Insufficiency and other conditions

United States, Canada
Worcester HIV Vaccine
Brigham and Women's Hospital; Access to Advanced Health Institute (AAHI)

Completed

Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults

HIV Infections

United States
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute

Active, not recruiting

A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)

COVID-19

Australia
GlaxoSmithKline

Active, not recruiting

Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection

Hepatitis B, Chronic

Taiwan, Belgium, Thailand, Germany, Spain, Hong Kong, United Kingdom, France, Poland
Speransa Therapeutics

Terminated

A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid Proteins

SARS-CoV-2 Infection

United States, Germany
PT Bio Farma
Fakultas Kedokteran Universitas Indonesia; Faculty of Medicine Universitas... and other collaborators

Completed

Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine

COVID-19

Indonesia
Cinnagen
Shahid Beheshti University of Medical Sciences; Vaxine Pty Ltd

Completed

Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine

COVID-19

Iran, Islamic Republic of
Clover Biopharmaceuticals AUS Pty Ltd

Withdrawn

Immunogenicity and Safety Study of SCB-2023 Vaccine as a Booster in Adults

COVID-19

Philippines
Emory University

Completed

Responses to Rabies Vaccine in Adults With or Without Antibiotics

Rabies Human

United States
University of Extremadura

Active, not recruiting

Influence of Co-diagnosis of Chronic Fatigue Syndrome in Patients With Fibromyalgia.

Fibromyalgia | Chronic Fatigue Syndrome | Comorbidities and Coexisting Conditions

Spain
International Vaccine Institute
Heidelberg University; International Centre for Diarrhoeal Disease Research... and other collaborators

Active, not recruiting

Mix and Match Heterologous Prime-Boost Study Using Approved COVID-19 Vaccines

Covid19

Madagascar, Mozambique
PT Bio Farma
Faculty of Medicine, Diponegoro University, Semarang; Faculty of Medicine,... and other collaborators

Completed

Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine

COVID-19

Indonesia
PT Bio Farma
Fakultas Kedokteran Universitas Indonesia; Faculty of Medicine, Diponegoro...

Completed

Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018

COVID-19

Indonesia
Gomel State Medical University

Enrolling by invitation

Humoral Immunity Study After Booster Vaccination of "Soberana Plus" (The Republic of Cuba) Against COVID-19

Humoral Immunity

Belarus
University Hospital Inselspital, Berne
University of Bern

Completed

Characterizing the Immune Response and Neuronal Damage in COVID-19

Covid-19 | SARS-CoV Infection

Switzerland
Adamis Pharmaceuticals Corporation

Terminated

Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients.

Covid19

United States
The University of Hong Kong

Suspended

Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the Community

Influenza, Human

Hong Kong
Cinnagen
Vaxine Pty Ltd

Completed

Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years

COVID-19

Iran, Islamic Republic of
Cinnagen
Vaxine Pty Ltd

Completed

Immunogenicity and Safety of a Booster Dose of the SpikoGen COVID-19 Vaccine

COVID-19

Iran, Islamic Republic of
Cinnagen
Vaxine Pty Ltd

Completed

Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)

Covid19

Iran, Islamic Republic of
Cinnagen
Vaxine Pty Ltd

Completed

Phase III Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)

Covid19

Iran, Islamic Republic of
Moscow Department of Health
Moscow State University of Medicine and Dentistry; National Research Center... and other collaborators

Completed

The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents

Covid19 | Respiratory Viral Infection

Russian Federation
Hellenic Cooperative Oncology Group

Completed

Responses to COVID-19 Vaccination in Patients With Cancer (ReCOVer)

Cancer

Greece
PT Bio Farma
National Institute of Health Research and Development, Ministry of Health... and other collaborators

Completed

Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine

Covid19

Indonesia
Chang Gung Memorial Hospital
Medigen Vaccine Biologics Corp.

Active, not recruiting

The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine

COVID-19 | Breakthrough Infection

Taiwan
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

HIV Infections

United States, Puerto Rico, Thailand, Botswana, Argentina, Brazil, Tanzania, South Africa
Eli Lilly and Company
GlaxoSmithKline; Shanghai Junshi Bioscience Co., Ltd.; Vir Biotechnology, Inc.; AbCellera Biologics Inc...

Completed

A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)

COVID-19

United States, Puerto Rico, Argentina
RAAS Nutritionals, LLC
Kayseri City Hospital

Completed

Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients

COVID-19 Pneumonia | COVID-19 Respiratory Infection | Bacterial Pneumonia | FLU | Cold; Influenza

Turkey
Boston University
National Institute of Allergy and Infectious Diseases (NIAID); Medical Research... and other collaborators

Completed

Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia

Pneumonia, Bacterial | Malaria | Plasmodium Falciparum Malaria | Viral Infection | Infections, Respiratory | Clinical Pneumonia

United States, Gambia, Netherlands
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccines, Given Individually or Co-administered, in Healthy, HIV-1-Uninfected Adults

HIV Infections

United States
Jiangsu Province Centers for Disease Control and...

Completed

Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine

COVID-19

China
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Biocine

Completed

A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.; MicroGeneSys Inc (nka Protein Sciences Corporation)

Completed

A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection

HIV Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (VaxSyn)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States, Tanzania
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Glaxo Wellcome; Upjohn

Completed

A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Biogen

Completed

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

HIV Infections

United States
GlaxoSmithKline

Completed

A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants

Respiratory Syncytial Virus Infections

Taiwan, Spain, United States, Italy, Canada, Panama, Mexico, Poland

Search clinical trials for: Viral Proteins

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations